Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models
出版年份 2011 全文链接
标题
Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models
作者
关键词
-
出版物
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 26, Issue 10, Pages 2452-2462
出版商
Wiley
发表日期
2011-06-30
DOI
10.1002/jbmr.455
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bisphosphonate-associated adverse events
- (2014) Peter Papapetrou Hormones-International Journal of Endocrinology and Metabolism
- Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis
- (2010) Jude Canon et al. BONE
- Glucose Transporter Protein 1–Targeted RNA Interference Inhibits Growth and Invasion of the Osteosarcoma Cell Line MG63 In Vitro
- (2010) Jian Fan et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models
- (2010) J Rousseau et al. CANCER GENE THERAPY
- Loss of Osteoclasts Contributes to Development of Osteosarcoma Pulmonary Metastases
- (2010) L. Endo-Munoz et al. CANCER RESEARCH
- Novel Bone-Targeted Strategies in Oncology
- (2010) S. Vallet et al. CLINICAL CANCER RESEARCH
- Pediatric osteogenic sarcoma
- (2010) Han Jo Kim et al. CURRENT OPINION IN PEDIATRICS
- Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease
- (2010) H.L. Neville-Webbe et al. EUROPEAN JOURNAL OF CANCER
- MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays
- (2010) S Kutscher et al. GENE THERAPY
- Preventing metastases to bone: Denosumab or bisphosphonates?
- (2010) Mark S Nanes JOURNAL OF BONE AND MINERAL RESEARCH
- Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: A retrospective medical records review
- (2010) MeiSheng Duh et al. Journal of Cancer Research and Therapeutics
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab for the Treatment of Osteoporosis
- (2010) Jameel Iqbal et al. Current Osteoporosis Reports
- Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing
- (2009) Yao Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- RNA Interference Technologies and Therapeutics
- (2009) Marta López-Fraga et al. BIODRUGS
- Control of RANKL gene expression
- (2009) Charles A. O'Brien BONE
- High-Dose Zoledronic Acid Impacts Bone Remodeling with Effects on Osteoblastic Lineage and Bone Mechanical Properties
- (2009) S. Pozzi et al. CLINICAL CANCER RESEARCH
- RANKL inhibition: Clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases
- (2009) Evangelos Terpos et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure
- (2009) Jean-Jacques Body et al. JOURNAL OF BONE AND MINERAL RESEARCH
- siRNA and Innate Immunity
- (2009) Marjorie Robbins et al. OLIGONUCLEOTIDES
- Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes
- (2008) Maroun Khoury et al. ARTHRITIS AND RHEUMATISM
- Risks and benefits of bisphosphonates
- (2008) R E Coleman BRITISH JOURNAL OF CANCER
- Current and future treatments of bone metastases
- (2008) JCM Clark et al. EXPERT OPINION ON EMERGING DRUGS
- Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates
- (2008) Ana O Hoff et al. JOURNAL OF BONE AND MINERAL RESEARCH
- RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
- (2008) R. E. Miller et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic efficacy of soluble receptor activator of nuclear factor-κB-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma
- (2008) François Lamoureux et al. MOLECULAR CANCER THERAPEUTICS
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
- (2008) Mark E. Kleinman et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now